Molecular mechanisms of enhanced vascular smooth muscle
Molecular mechanisms of enhanced vascular smooth muscle
批准号:
7294621
负责人:
Coleen A McNamara
金额:
$26.05万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-08-04 至 2011-07-31
关键词:
apolipoprotein Ecardiovascular injurycell proliferationchromatin immunoprecipitationgel mobility shift assaygenetic regulatory elementgenetic transcriptionhyperlipidemiainsulin sensitivity /resistancelaboratory mouselipoxygenasenoninsulin dependent diabetes mellituspathogenic dietphosphorylationserinesite directed mutagenesistissue /cell culturetransfectionvascular smooth muscle
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The molecular mechanisms that lead to increased restenosis in T2DM are unknown. Vascular smooth
muscle cell (VSMC) proliferation plays a key role in restenosis following vascular injury, and glucose, insulin,
and oxidative stress increase VSMC growth. Moreover, in animal models of T2DM, there is increased
VSMC proliferation in response to injury. Leukocyte type 12/15 lipoxygenase (12LO) has been implicated
as a key mediator of enhanced VSMC proliferation and neointimal formation in response to injury in animal
models of T2DM. Our preliminary data clearly demonstrates that 12LO regulates VSMC growth, one
potential mechanism for the accelerated response to injury in diabetes. We further demonstrate that 12LO-induced
proliferation of VSMC is mediated by the helix-loop-helix transcription factor Id3 (a key regulator of
insulin and glucose mediated gene transcription). We have demonstrated in multiple models of insulin
resistance and type 2 DM, that Id3 expression is significantly increased. Mechanistic studies demonstrate
that Id3 promotes G1-S transition leading to increased VSMC growth and that phosphorylation of Id3 on
serine 5 regulates this event. In this renewal application, we propose to extend our in vitro mechanistic
findings and previous in vivo expression studies to demonstrate that the 12LO/ld3 pathway is a key mediator
of the vascular response to injury in vivo in animals models of type 2 DM. Furthermore, we propose to
identify the cis and trans-acting elements that mediate 12LO-induced increases in Id3 expression and
VSMC growth and confirm their role in vivo in the response to injury in T2DM .
Hypotheses: Type 2 DM modulates the response to vascular injury via regulation of Id3 expression and
activity and VSMC growth. This effect is mediated by 12LO-induced nuclear factor expression leading to
enhanced Id3 expression and/or serine 5 phosphorylation of Id3. To extend our exciting findings from
VSMC culture studies in vivo in an animals model of vascular response to injury in T2DM and to address this
central hypothesis, we propose the following aims. Aim 1: Establish the essential role of Id3 in the
accelerated neointimal formation in response to injury in diet-induced mouse models of type 2 DM.
Aim 2: Evaluate in vivo the 12LO/ld3 pathway leading to accelerated VSMC growth and lesion formation.
Aim 3c. Extend in vitro findings in vivo to confirm that the 12LO-response elements in the Id3 promoter
required for Id3 transcription in culture also regulate Id3 transcription in vivo in response to injury in T2DM.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Id3 and VSMC in Murine and Human Atherosclerosis
-
批准号:10004164
-
项目类别:
-
资助金额:$67.1万
-
财政年份:2019
-
负责人:Coleen A McNamara
-
依托单位:
Id3 and VSMC in Murine and Human Atherosclerosis
-
批准号:10421070
-
项目类别:
-
资助金额:$67.1万
-
财政年份:2019
-
负责人:Coleen A McNamara
-
依托单位:
Id3 and VSMC in Murine and Human Atherosclerosis
-
批准号:10210435
-
项目类别:
-
资助金额:$67.1万
-
财政年份:2019
-
负责人:Coleen A McNamara
-
依托单位:
Somatic TET2 mutation-driven clonal hematopoiesis in atherosclerosis
-
批准号:10397523
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2018
-
负责人:Coleen A McNamara
-
依托单位:
Somatic TET2 mutation-driven clonal hematopoiesis in atherosclerosis
-
批准号:9913594
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2018
-
负责人:Coleen A McNamara
-
依托单位:
B Cell Subsets in Mouse and Human Atherosclerosis
-
批准号:10188607
-
项目类别:
-
资助金额:$36.65万
-
财政年份:2017
-
负责人:Coleen A McNamara
-
依托单位:
Project 3: Regulation of atheroprotective IgM - producing B cells in murine and human atherosclerosis
-
批准号:10334096
-
项目类别:
-
资助金额:$4.31万
-
财政年份:2017
-
负责人:Coleen A McNamara
-
依托单位:
Genetic Regulation of B Lymphocyte Aortic Homing and Atheroprotection
-
批准号:8433454
-
项目类别:
-
资助金额:$36.65万
-
财政年份:2011
-
负责人:Coleen A McNamara
-
依托单位:
Genetic Regulation of B Lymphocyte Aortic Homing and Atheroprotection
-
批准号:8607987
-
项目类别:
-
资助金额:$37.73万
-
财政年份:2011
-
负责人:Coleen A McNamara
-
依托单位:
Genetic Regulation of B Lymphocyte Aortic Homing and Atheroprotection
-
批准号:8243525
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2011
-
负责人:Coleen A McNamara
-
依托单位:
Genetic Regulation of B Lymphocyte Aortic Homing and Atheroprotection
-
批准号:8083888
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2011
-
负责人:Coleen A McNamara
-
依托单位:
Molecular mechanisms of enhanced vascular smooth muscle cell growth in diabetes
-
批准号:8098766
-
项目类别:
-
资助金额:$25.47万
-
财政年份:2010
-
负责人:Coleen A McNamara
-
依托单位:
Id3/B Lymphocytes and Atherosclerosis
-
批准号:7753076
-
项目类别:
-
资助金额:$51.17万
-
财政年份:2009
-
负责人:Coleen A McNamara
-
依托单位:
Id3/B Lymphocytes and Atherosclerosis
-
批准号:7923948
-
项目类别:
-
资助金额:$49.82万
-
财政年份:2009
-
负责人:Coleen A McNamara
-
依托单位:
Molecular mechanisms of enhanced vascular smooth muscle cell growth in diabetes
-
批准号:7478342
-
项目类别:
-
资助金额:$31.49万
-
财政年份:2007
-
负责人:Coleen A McNamara
-
依托单位:
Id3 Regulation of Smooth Muscle Cell Proliferation
-
批准号:6924326
-
项目类别:
-
资助金额:$34.29万
-
财政年份:1999
-
负责人:Coleen A McNamara
-
依托单位:
ID3 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION
-
批准号:6390338
-
项目类别:
-
资助金额:$27.23万
-
财政年份:1999
-
负责人:Coleen A McNamara
-
依托单位:
Id3 Regulation of Smooth Muscle Cell Proliferation
-
批准号:7221905
-
项目类别:
-
资助金额:$32.53万
-
财政年份:1999
-
负责人:Coleen A McNamara
-
依托单位:
ID3 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION
-
批准号:6184999
-
项目类别:
-
资助金额:$26.44万
-
财政年份:1999
-
负责人:Coleen A McNamara
-
依托单位:
ID3 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION
-
批准号:6527460
-
项目类别:
-
资助金额:$28.05万
-
财政年份:1999
-
负责人:Coleen A McNamara
-
依托单位:
海外基金